{
    "organizations": [],
    "uuid": "6e7994d7d4419a68ddd56463977b255b79992ef8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-engage-therapeutics-doses-first-pa/brief-engage-therapeutics-doses-first-patient-in-phase-2b-trial-of-epilepsy-seizure-rescue-therapy-staccato-alprazolam-idUSASC09ZHR",
    "ord_in_thread": 0,
    "title": "Engage Therapeutics Doses First Patient In Phase 2B Trial Of Epilepsy Seizure Rescue Therapy Staccato Alprazolam",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) -\n* ENGAGE THERAPEUTICS DOSES FIRST PATIENT IN PHASE 2B TRIAL OF EPILEPSY SEIZURE RESCUE THERAPY STACCATOÂ® ALPRAZOLAM Source text for Eikon:\nOur ",
    "published": "2018-05-03T19:42:00.000+03:00",
    "crawled": "2018-05-04T16:57:55.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "engage",
        "therapeutic",
        "dos",
        "first",
        "patient",
        "phase",
        "2b",
        "trial",
        "epilepsy",
        "seizure",
        "rescue",
        "therapy",
        "alprazolam",
        "source",
        "text",
        "eikon"
    ]
}